Literature DB >> 7846028

Crystallization and characterization of the recombinant human Clara cell 10-kDa protein.

J H Matthews1, N Pattabiraman, K B Ward, G Mantile, L Miele, A B Mukherjee.   

Abstract

Crystals of recombinant human Clara cell 10-kDa protein were grown both from ammonium sulfate and polyethylene glycol (PEG) solutions. Crystals grown from ammonium sulfate solution have been characterized by X-ray diffraction studies as monoclinic with the space group C2 and lattice constants a = 69.2 A, b = 83.0 A, c = 58.3 A, and beta = 99.7 degrees. The monoclinic crystals diffract to beyond 2.5 A. Some of the crystals grown from PEG were of a similar habit to those grown from ammonium sulfate, but others were triclinic with the space group P1 and cell constants a = 40.3 A, b = 46.3 A, c = 51.3 A, alpha = 117.7 degrees, beta = 102.3 degrees, and gamma = 71.4 degrees. These crystals diffract to beyond 3.2 A.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846028     DOI: 10.1002/prot.340200209

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  3 in total

Review 1.  Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Maria E Laucho-Contreras; Francesca Polverino; Yohannes Tesfaigzi; Aprile Pilon; Bartolome R Celli; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2016-02-11       Impact factor: 6.902

2.  Recombinant human uteroglobin suppresses cellular invasiveness via a novel class of high-affinity cell surface binding site.

Authors:  G C Kundu; G Mantile; L Miele; E Cordella-Miele; A B Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

3.  Uteroglobin represses allergen-induced inflammatory response by blocking PGD2 receptor-mediated functions.

Authors:  Asim K Mandal; Zhongjian Zhang; Rabindranath Ray; Moonsuk S Choi; Bhabadeb Chowdhury; Nagarajan Pattabiraman; Anil B Mukherjee
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.